$6,000 invested in this ASX 200 stock 5 years ago is now worth $84,000!

ASX 200 investors who bought this growth stock five years ago have achieved remarkable gains.

| More on:
Lab worker puts hands in the air and dances around

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Not every S&P/ASX 200 Index (ASX: XJO) stock is going to shoot the lights out and deliver 10-bagger plus returns in just five years.

Indeed, some will invariably head in the other direction and erode the value of your initial investment over time.

Which is why we always stress the importance of a properly diversified investment portfolio.

The equities part of that portfolio should ideally comprise a range of companies operating in various sectors and locations.

And if one of those companies happens to be an ASX 200 stock like Telix Pharmaceuticals Ltd (ASX: TLX), so much the better!

Created with Highcharts 11.4.3Telix Pharmaceuticals PriceZoom1M3M6MYTD1Y5Y10YALL21 Oct 201912 Feb 2025Zoom ▾Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25202020202021202120222022202320232024202420252…20252…www.fool.com.au

ASX 200 stock still running strong

Telix is a biopharmaceutical company primarily focused on developing diagnostic and therapeutic products to help treat different types of cancer.

Over the past 12 months alone, the Telix Pharmaceuticals share price has surged 155%, and even touched a record high of $22.38 in opening trading yesterday.

But if you'd bought shares in the ASX 200 stock five years ago, you'd really be laughing.

Five years ago, you could have picked up those same shares for $1.55 apiece.

That means for $6,000, you could have bought 3,870 shares with some pocket change left over.

In late afternoon trading yesterday, Telix shares were swapping hands for around $21.70 apiece. This means your 3,870 shares bought five years ago are now worth almost $84,000.

That's a gain of 1,300%. In five years.

For some context, the ASX 200 has gained around 23.7% over this same period.

How's that for some outperformance?

What's driving the Telix Pharmaceuticals share price higher?

If you look back at the chart above, you'll see that the ASX 200 stock has been trending higher for almost all of the past five years.

Now, that's too much time for us to cover in this article.

However, the company's 2023 calendar year results (reported on 22 February 2024) are quite indicative of the growth story that's been spurring investor interest.

In 2023 Telix Pharmaceuticals reported revenue of $502.5 million, up 214% from 2022.

The company also achieved earnings before interest, taxes, depreciation and amortisation (EBITDA) of $58.4 million, which compared very favourably to its $67.8 million loss in 2022.

This saw the ASX 200 biotech stock deliver its inaugural full-year profit of $5.2 million after tax, compared to the net loss after tax of $104.1 million in 2022.

Telix CEO Christian Behrenbruch commented at the time:

We have achieved profitability while intensively investing in the development of our late-stage assets and the scale-up of our commercial infrastructure and marketing activity.

This has resulted in Telix capturing a meaningful market share in the growing urology imaging market whilst laying the foundation for our next commercial products.

And growth has continued for the first half of 2024, with H1 revenue up 65% year on year to $364 million and gross margins improving by 3% to 66%.

Should you invest $1,000 in Telix Pharmaceuticals right now?

Before you buy Telix Pharmaceuticals shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Telix Pharmaceuticals wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 7 February 2025

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

People sit in rollercoaster seats with expressions of fear, terror and exhilaration as it goes into a steep downward descent representing the Novonix share price in FY22
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a rough end to the trading week this Friday.

Read more »

Siblings jumping on a trampoline.
Share Gainers

These 3 ASX 200 stocks are charging higher this week. Own any?

Investors have been piling into these ASX 200 stocks this week. But why?

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Domino's, Nick Scali, REA, and Sigma shares are charging higher today

These shares are ending the week on a high. Let's see why investors are bidding them higher today.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why BWP, Magellan, News Corp, and Winsome shares are pushing higher today

These shares are having a better day than most on Thursday. But why?

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX was back in form this hump day...

Read more »

A boy stands firm on a rocky cliff holding a rocket in each hand and looking up toward the sky, anticipating flying into space.
Resources Shares

Up 864% in a year, how this ASX mining stock is primed to keep rocketing in 2025

The ASX mining stock looks to be in a sweet spot amid export bans from China and Russia.

Read more »

Happy coal miner.
Energy Shares

Why are ASX coal shares having such a cracking run today?

The latest salvo in the new American tariff war is benefiting some ASX shares.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Share Gainers

Why BWP, Insignia, Nufarm, and Pinnacle shares are charging higher today

These shares are having a good time on hump day. But why?

Read more »